Epizyme (EPZM) PT Lowered to $18 at Roth Capital

October 22, 2018 11:27 AM EDT Send to a Friend

Roth Capital analyst Jotin Marango ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Epizyme (EPZM) PT Lowered to $18 at Roth Capital

Member Login

Free News Feed